vaccine

[rogruth]

My wife and I got our first shot yesterday, 1/27/2021, at noon. They wanted a copy of our medical insurance card.
There were no lines. Everyone at this site was scheduled a time. We were asked to stay for ten minutes after the
shot in case there were any reactions. My arm is sore but does not hurt.
We are scheduled for the second shot in February.

[MurphOnMillerAve]

Glad to have your approval, Rufybabes.

Just remember this in no way renders you invulnerable; hope you are scheduled for you 2nd dose, too.

Yes, sir, they sent me e-mail confirmation of that date, too, including the exact time I was expected to be there. Nice.

[robert.]

[quote="robert.". Philly fighting covid turned to a for profit group and sold patients' info.

What kind of patients info Their medical records Who would they sell that information to and what would it be useful for.

Medical records are pretty seriously protected by all sorts of laws; mainly privacy issues but then depending on the extent of the records insurance and pharma.

An online sources says " they made a change to their privacy policy."

[robert.]

It's possible nothing was sold. just a change in terms. I think the big kicker was the change to for profit
https://whyy.org/articles/whats-actuall ... cy-policy/

[MurphOnMillerAve]

Once a person has received a vaccine, like Moderna's 2-part , can we, later down the calendar, get Johnson&Johnson's when it's ready?

[MartyE]

Once a person has received a vaccine, like Moderna's 2-part , can we, later down the calendar, get Johnson&Johnson's when it's ready?

That would seem repetitive. I guess there wouldn't be any harm but Neil probably could weigh in more on that. Seems once you have been vaccinated, at least until the vaccine is more readily available, I would let others get their before double dipping. I can't see why though once out there and easy to come by why if required every year another brand would make a difference.

[Rufus T. Firefly]

Once a person has received a vaccine, like Moderna's 2-part , can we, later down the calendar, get Johnson&Johnson's when it's ready?

Why? If you've gotten both parts of either of the 2-dose vaccines, you're done for now.

Only reason to get another vaccine in the future would be to cover one of the mutated strains that the Moderna may not be efficacious against.

The J&J vaccine is also something completely different. In any case, if you're covered, let someone else get vaccinated.

[MurphOnMillerAve]

Thank you,Rufus.

[Rufus T. Firefly]

Thank you,Rufus.

You all scheduled for your 2nd dose?

[MartyE]

Thank you,Rufus.

You all scheduled for your 2nd dose?

I don't qualify yet for the vaccine. We are supposedly under the "Media Umbrella" in the 3rd round before the general public.

I'll get it when available but there are certainly folks out there that need it more than I do. I can wait if I have to.

[MurphOnMillerAve]

Thank you,Rufus.

You all scheduled for your 2nd dose?

Yes. They sent me an e-note designating date & time . I'll be there .

[HONDO74]

Covid vaccine: Single-dose Johnson & Johnson jab is 66% effective
https://www.bbc.com/news/health-55857530

A single-dose coronavirus vaccine developed by Janssen is 66% effective, the Belgian company has announced.

Crucially, no one needed hospital treatment or died from Covid after the jab took effect in the international trial.

Health secretary Matt Hancock said if the jab was approved by the UK's regulator it could "significantly bolster" the vaccine programme.

The UK has ordered 30 million doses of Johnson & Johnson's Janssen jab.

Prime Minister Boris Johnson said that the results from the early trials were "very encouraging" and if approved - by the Medicines and Healthcare Products Regulatory Agency (MHRA) - doses of the jab should be available later this year.

The trial looked at giving just one dose of the vaccine, which makes it significantly easier to roll out than those requiring two.

Although there are also signs the jab is less effective against the new variant that is spreading in South Africa.

The trial looked at giving just one dose of the vaccine, which makes it significantly easier to roll out than those requiring two.

Although there are also signs the jab is less effective against the new variant that is spreading in South Africa.

The news comes shortly after Novavax announced their jab was 89% effective overall in the UK and 60% in South Africa. Both new vaccines will need to be reviewed by regulators before they can be used.

Janssen - which is owned by the pharmaceutical firm Johnson & Johnson - is also investigating whether giving two doses will give either stronger or longer-lasting protection.

[Neil]

I agree with Rufus's points above. No reason for a different second vaccine for those vaccinated or a booster until there is evidence for one or both of the following (1) immunity wanes sufficiently that vaccinees are vulnerable to reinfection (booster such as is done for tetanus toxin--that's every ten years or so) and/or (2)virus mutates so that an additional vaccination seems prudent (essentially why one gets an annual influenza shot---the virus changes).

Indeed, most of us are convinced that if we could at least one shot into the arm of 70-90% of the population the pandemic would largely be over if we continued to observe some basic public health measures (masks indoors in public venues, hand washing protocols). Unless the virus mutates very rapidly and in the direction of becoming sufficiently different, the current vaccine should protect against widespread infection, and one shot is a lot better than none. Two is even better. But it's coverage of the population that is key in all likelihood, not dosing or even precise efficacy.

[robert.]

I think you’ll be lucky to see 50 percent vaccinated.

[Rufus T. Firefly]

I think you’ll be lucky to see 50 percent vaccinated.

Eventually vaccination will be a condition for attending school and employment.